CubaPLUS Magazine

The Center for Pharmaceutical Research and Development (CIDEM, in Spanish) is a closed-cycle company that belongs to BioCubaFarma Group. It has more than 25 years of experience in the Cuban biopharmaceutical sector, focused on research and development activity for the subsequent transference of technologies to the industry and the marketing of innovative, generic and naturally-derived pharmaceutical products.

CIDEM has developed more than 450 generic products which are included in the Cuban Baste List of Drugs. These products have been introduced to the Cuban pharmaceutical industry to satisfy the population's demand as part of the import substitution program and to expand the therapeutic arsenal of the National Healh System.

In a statement prepared for the CubaPlus Magazine, Alejandro Saul Padron Yaquis, PhD, CIDEM General Director, highlighted that the Institution has played an important role in the scientific development and diversification of the Cuban biopharmaceutical industry. Currently, its mission is: "To encourage innovation on new chemical, biological and therapeutic entities, enhanced through academic and commercial collaborations or negotiations at national and international levels, and to promote the development and technology transference of generic drugs and natural products. For this, we have a quality system that harmoniously intertwines organization, qualified personnel and resources, mntributing to improve National Health System levels and the scientific and socioeconomic development of our country".

Its research-development lines are mainly focused on:
bull; Innovative Products: Concerned to a high impact on world health due to the treatment of life-threatening diseases, such as Alzheimer's, Parkinson's, Ischemia, neuropathic pain, infectious diseases, depression and cancer.
bull; High Technology Generic Products: Development of advanced drug delivery systems.
bull; Conventional Generic Products: To increase and update Basic List of Drugs.
bull; Selected Natural Products: Technological development and industrial introduction of new formulations.
bull; Selected Diagnosticians: Alternative methods for detection and control of pyrogens in parenteral products.
bull; Health-related products: Related to disinfection and water treatment.

At the international scope, CIDEM has collaboration with scientific institutions from more than 15 countries from Europe, Asia, Central America and the Caribbean. In 2019, it established scientific collaboration with the Skolkovo Innovation Technology Park, in Russia, for the co-development of innovative products.

Scientific Collaboration
CIDEM has collaboration with dissimilar Cuban academic, scientific and productive institutions, giving special attention to productive chains and the university-company alliance. As an example of the latter, the Joint Laboratory for Chemical and Biomolecular Synthesis (University of Havana-BioCubaFarma) was recently inaugurated, fruit of the coordination between Faculty of Chemistry and CIDEM. This will contribute to the training of future professionals in this field, accelerating those results of joint projects with innovative molecules, referred the director.

Business Opportunities
The company has a Portfolio of Business Opportunities that indudes several modalities of joint work for its main lines and research projects.

CIDEM is organizing the International Congress on Research, Development and Technological Innovation of the Biopharmaceutical Industry, 101 FARMA, which will take place in Havana, Cuba, from November 29th to December 3rd, 2021 . IDIFARMA constitutes a proper space for the presentation of scientific results, product exhibition and interchange of experiences among Cuban and foreign professionals.

Contact
1605 Ave 26 b/ Boyeros and Puentes Grandes, Plaza de Ia Revolución.
Havana. Cuba
General Direction phones: +53 7881-0830 / 7-881-0818 / Mobile: 52794193
Email: direccion@cidem.cu
Website: www.cidem.cu
Facebook: CIDEM.farmaceutica
Twitter: @CIDEM_Cuba